| Cat. No. |
Product Name |
Information |
| PC-20633 |
TR120
STAT5 inhibitor
|
TR120 (TR-120) is a potent small molecule STAT5 inhibitor, exhibits antiproliferative in K562 cells with IC50 of 0.12 uM, decreases STAT5 expression in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells. |
| PC-20632 |
STAT3 inhibitor LY5
STAT3 inhibitor
|
STAT3 inhibitor LY5 is a specfic STAT3 small molecule inhibitor, binds to STAT3 SH2 domain wioth Kd of 2.5 uM. |
| PC-20631 |
BP-1-108
STAT5 inhibitor
|
BP-1-108 is a small molecule STAT5-SH2 domain inhibitor with Ki of 2.8 uM, shows weak affinity for Stat1 and Stat3 (Ki, 9,7 and 8.0 uM respectively). |
| PC-20630 |
SF-1-088
STAT5 inhibitor
|
SF-1-088 is a small molecule STAT5-SH2 domain inhibitor with Ki of 8.3 uM (Stat5b), shows no affinity for Stat1 and Stat3 (Ki>25 uM). |
| PC-20629 |
SF-1-066
STAT3 inhibitor
|
SF-1-066 is an orally bioavailable inhibitor of STAT3 with IC50 of 35 uM for inhibition of STAT3 DNA binding activity in vitro, binds to the STAT3 SH2 domain and inhibits STAT3 dimerization. |
| PC-20628 |
S3I-1757
STAT3 inhibitor
|
S3I-1757 is a small molecule STAT3-STAT3 dimerization inhibitor with IC50 of 13.5 uM in fluorescence polarization (FP) assays, interacts with Y-705 binding site in the SH2 domain. |
| PC-20627 |
W2014-S
STAT3 inhibitor
|
W2014-S is a small molecule STAT3 inhibitor with binding Kd of 3.64 uM, disrupts STAT3 dimerization and selectively inhibits STAT3 signaling. |
| PC-20605 |
STAT3 inhibitor DG-4
TrxR1 inhibitor
|
DG-4 is a potent, selective inhibitor of STAT3-dependent transcription with IC50 of 0.12 uM in IL6-STAT3 luciferase reporter assays, 44-fold selectivity over IFN-γ STAT1. |
| PC-49781 |
MC0704
STAT3 inhibitor
|
MC0704 (MC-0704) is a novel synthetic STAT3 pathway inhibitor, exhibits potential antitumor activity in vitro and in vivo models in docetaxel-resistant TNBC cells. |
| PC-38627 |
STAT3 inhibitor N4
STAT3 inhibitor
|
STAT3 inhibitor N4 is a small molecule capable of inhibiting the STAT3 SH2 domain with IC50 of 0.57 uM, SPR KD of 1.04 uM, inhibits STAT3 dimerization and transcription in vitro and suppresses pancreatic cancer in vivo. |
| PC-70276 |
OPB-51602
|
A novel small molecule SH2 domain-targeting STAT3 inhibitor with IC50/Kd of 7.3/5 nM. |
